a
Today's Top 20 StoriesRSS
The Harvard Business Review profiled Phoenix-based The CORE Institute's new condition-based approach to eliminating unnecessary care as an alternative to procedure-based bundled payments.  By Laura Dyrda -
Stryker CEO Kevin Lobo appeared on CNBC's Squawk CEO Call to discuss several aspects of the business and where his company is headed in the future.  By Laura Dyrda -
Medscape's Editor-in-Chief, Eric Topol, MD, shared some technologies he believes will impact medicine and greatly benefit patients.  By Megan Wood -

Are you positioned to shine or fade under MACRA?

Sponsored
Learn how to break down the barriers to success under value-driven health care and outline the baseline needs for education, program management, and model implementation.
Walnut Creek, Calif.-based Providence Medical Technology closed a new equity financing round of $10.5 million.  By Megan Wood -
Farmingdale, N.Y.-based Misonix named Stavros G. Vizirgianakis the new president and CEO, effective immediately, according to StreetInsider.com.  By Megan Wood -
An HHS inspector general report found Medicare beneficiaries may face higher hospital bills for outpatient procedures, as opposed to inpatient, according to Herald-Tribune.  By Mary Rechtoris -
Matthew Link, San Diego-based NuVasive's president of U.S. commercial, sold 10,303 company shares on Dec. 12, 2016, according to The Market Digest.  By Megan Wood -

Major factors for preserving anesthesia excellence at Academic Medical Centers

Sponsored
Join this webinar to learn the insights and tools that will help you run a more efficient academic OR Department.
With President Barack Obama signing the 21st Century Cures Act into law on Dec. 13, 2016, the field of regenerative medicine and stem cell therapies stands to benefit.  By Megan Wood -
Daniel J. McGuire, MD, moved his practice to northwest Iowa, according to The Daily Reporter.  By Megan Wood -
Several years ago, Eric Monesmith, MD, was approached by a friend who represented companies in the orthopedic industry about a new method that could improve pain management protocols for patients — genetic testing. The tests show providers how patients' genetics impact their ability to metabolize different categories of medications, notably narcotics. Dr. Monesmith has been utilizing genetic testing for total joint procedures at Indianapolis-based OrthoIndy for nearly two years and has seen success managing patients' postoperative pain.  By Mary Rechtoris -
Tampa-based Laser Spine Institute hosted the inaugural Calusa Ambulatory Spine Conference in Streamsong, Fla., from Nov. 11 through Nov. 13, 2016. The conference offered spine care specialists information on the treatment of spine disorders in ambulatory settings.  By Megan Wood -
Minimally invasive spine surgeon Timothy Roberts, MD, joined Coastal Orthopedics Sports Medicine & Pain Management in Bradenton, Fla., according to a Herald Tribune report. By Laura Dyrda -
Inflation outpaces medical malpractice insurance premium increases for some physicians in many regions, according to a Medscape report. By Laura Dyrda -
Mark Richards, Director of Marketing Communications, Events and Services at Zimmer Biomet Spine, discusses the company's two major acquisitions of 2016 and where Zimmer Biomet plans to grow in the spine space going forward. By Laura Dyrda -
The global sports medicine market is expected to grow at a compound annual growth rate of 6.8 percent though 2022, according to a Wise Guy Reports.  By Megan Wood -
In October 2016, Titan Spine initiated the full U.S. launch of its nanoLOCK surface technology on its line of Endoskeleton titanium interbody implants and doubled the size of its sales management team. The nanoLOCK technology is now used in30 hospitals across 19 states, and Titan is currently in the process of signing contracts with several other large health systems.  By Laura Dyrda -
The global wearable medical devices market is set to reach $12.14 billion by 2021, up from $5.31 billion in 2016, based on a Research and Markets report.  By Megan Wood -
The global non-fusion spinal devices market is expected to grow between 2015 and 2025.  By Megan Wood -
Tom Price, MD, President-elect Donald Trump's pick for HHS secretary, has received a large portion of funding from medical specialists, according to The News Tribune.  By Mary Rechtoris -
France-based Safe Orthopaedics received the CE Mark for an upgraded version of its patented Oak screw.  By Megan Wood -
Page 11 of 50

Featured Whitepapers

Webinars

Top 40 Articles from the Past 6 Months